Lactic Acid

Lactic Acid

SCHEMBL428727

CC(O)C(=O)O.CCCCCCCCCCCCCCCCCCCCCC(=O)NCCCN(C)C

nearest known ligand 0.80

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

CHRM1DRD2DRD3DRD4HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HTR2APDE3ASIGMAR1

The experimentally established mechanism targets of Lactic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
DNM1 Q05193 2/20 0.80
FAAH O00519 8/20 0.53
NAAA Q02083 1/20 0.51
CASP2 P42575 1/20 0.50
EPHX2 P34913 3/20 0.49
NOD1 Q9Y239 1/20 0.47
KDM4E B2RXH2 1/20 0.46
SELP P16109 1/20 0.46
MEN1 O00255 1/20 0.45
MAPK1 P28482 1/20 0.45
KMT2A Q03164 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Lactic Acid SCHEMBL3336829 1.00 DNM1 (0.80) DNM1FAAHNAAACASP2EPHX2
Lactic Acid SCHEMBL3863099 1.00 DNM1 (0.80) DNM1FAAHNAAACASP2EPHX2
Lactic Acid SCHEMBL128277 1.00 DNM1 (0.80) DNM1FAAHNAAACASP2EPHX2
Lactic Acid SCHEMBL25266814 0.93 DNM1 (0.79) DNM1FAAHNAAACASP2EPHX2
Lactic Acid SCHEMBL432082 0.92 DNM1 (0.68) DNM1FAAHEPHX2KDM4EMEN1
Lactic Acid SCHEMBL28053597 0.92 DNM1 (0.68) DNM1FAAHEPHX2KDM4EMEN1
SCHEMBL8660980 0.89 DNM1 (1.00) DNM1FAAHNAAACASP2EPHX2
SCHEMBL5383341 0.89 DNM1 (1.00) DNM1FAAHNAAACASP2EPHX2
SCHEMBL9565176 0.89 DNM1 (1.00) DNM1FAAHNAAACASP2EPHX2
SCHEMBL19281112 0.89 DNM1 (1.00) DNM1FAAHNAAACASP2EPHX2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 68 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080113892-A1 Antimicrobial wash formulations including amidoamine-based cationic surfactants SILVER POINT FINANCE, LLC, AS COLLATERAL AGENT 2008-05-15 US claimed
US-20020155962-A1 Nonaqueous hair styling composition and method of use ANDREW JERGENS COMPANY, THE 2002-10-24 US claimed
CN-119768150-A Hair treatment method 花王株式会社 2025-04-04 CN disclosed
US-20240407989-A1 METHOD FOR TREATING KERATINOUS MATERIAL KAO CORPORATION (JP) 2024-12-12 US disclosed
EP-4413973-A1 METHOD FOR TREATING KERATINOUS MATERIAL Kao Corporation (JP) 2024-08-14 EP disclosed
US-20230372207-A1 CARBONATED AEROSOL EXTERNAL PREPARATION FOR SKIN KAO CORPORATION (JP) 2023-11-23 US disclosed
EP-4223370-A1 CARBONATED AEROSOL FOR TOPICAL USE Kao Corporation (JP) 2023-08-09 EP disclosed
EP-3101407-B1 KIT AND METHOD FOR ELECTRON MICROSCOPE OBSERVATION JAPAN SCIENCE & TECH AGENCY (JP) 2023-03-08 EP disclosed
US-11447640-B2 Encapsulated materials with improved properties SUN CHEMICAL CORPORATION (US) 2022-09-20 US disclosed
CN-114259414-A Hair cosmetic 株式会社资生堂 2022-04-01 CN disclosed
CN-110950606-B Concrete with antirust function and application process thereof 浙江众汇交通工程有限公司 2021-11-09 CN disclosed
US-6919076-B1 Conjugates of agents and transglutaminase substrate linking molecules PERICOR SCIENCE, INC. (US) 2005-07-19 US disclosed
US-6706674-B2 CONTAINING A VINYL INTERPOLYMER SUCH AS A VINYL ACETATE-VINYL PYRROLIDONE COPOLYMER OR TERPOLYMER WITH VINYL PROPIONATE OR SODIUM ACRYLATE-VINYL ALCOHOL COPOLYMER THE ANDREW JERGENS COMPANY 2004-03-16 US disclosed
EP-1303260-A2 LINKAGE OF AGENTS USING MICROPARTICLES Pericor Science, Inc. (US) 2003-04-23 EP disclosed
US-20020155962-A1 Nonaqueous hair styling composition and method of use ANDREW JERGENS COMPANY, THE 2002-10-24 US disclosed
EP-1203141-A1 LINKAGE OF AGENTS TO TISSUE Pericor Science, Inc. (US) 2002-05-08 EP disclosed
EP-1202706-A1 LYSINE OXIDASE LINKAGE OF AGENTS TO TISSUE Pericor Science, Inc. (US) 2002-05-08 EP disclosed
WO-2002007707-A2 LINKAGE OF AGENTS USING MICROPARTICLES PERICOR SCIENCE, INC. (US) 2002-01-31 WO disclosed
WO-2001007009-A1 LYSINE OXIDASE LINKAGE OF AGENTS TO TISSUE PERICOR SCIENCE, INC. (US) 2001-02-01 WO disclosed
WO-2001006829-A2 LINKAGE OF AGENTS TO TISSUE PERICOR SCIENCE, INC. (US) 2001-02-01 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230372207-A1 CARBONATED AEROSOL EXTERNAL PREPARATION FOR SKIN CERT1, CERS2, SGMS2 DNM1 1204/4885FAAH 1608/4885NAAA 1558/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.